期刊
JOURNAL OF IMMUNOLOGY
卷 200, 期 3, 页码 897-907出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1701414
关键词
-
类别
资金
- International Anesthesia Research Society Mentored Research Award
- National Institutes of Health [P50-CA098258, DK056338, R01-DK097075, R01-HL098294, POI-HL114457, R01-DK082509, R01-HL109233, R01-DK109574, R01-HL119837, R01-HL133900]
- NATIONAL CANCER INSTITUTE [P50CA098258] Funding Source: NIH RePORTER
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119837, R01HL109233, R01HL133900, P01HL114457, R01HL098294] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082509, R01DK109574, R01DK097075, P30DK056338] Funding Source: NIH RePORTER
Intestinal inflammation is a key element in inflammatory bowel disease and is related to a combination of factors, including genetics, mucosal barrier dysfunction, bacteria translocation, deleterious host-microbe interactions, and dysregulated immune responses. Over the past decade, it has been appreciated that these inflammatory lesions are associated with profound tissue hypoxia. Interestingly, an endogenous adaptive response under the control of hypoxia signaling is enhancement in adenosine signaling, which impacts these different endpoints, including promoting barrier function and encouraging anti-inflammatory activity. In this review, we discuss the hypoxia-adenosine link in inflammatory bowel disease, intestinal ischemia/reperfusion injury, and colon cancer. In addition, we provide a summary of clinical implications of hypoxia and adenosine signaling in intestinal inflammation and disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据